JFNIX | RYCFX | JFNIX / RYCFX | |
Total Expense Ratio | 0.77 | 2.38 | 32% |
Annual Report Gross Expense Ratio | 0.77 | 2.43 | 32% |
Fund Existence | 16 years | 25 years | - |
Gain YTD | 3.176 | 10.589 | 30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.49B | 89.1M | 5,034% |
Annual Yield % from dividends | 0.39 | 0.00 | - |
Returns for 1 year | -12.39 | -15.50 | 80% |
Returns for 3 years | 21.30 | 2.93 | 726% |
Returns for 5 years | 8.34 | -36.62 | -23% |
Returns for 10 years | 39.28 | -33.80 | -116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RLUEX | 12.57 | N/A | N/A |
Lazard US Equity Concentrated R6 | |||
FBDIX | 143.61 | N/A | N/A |
Franklin Biotechnology Discovery A | |||
CFSIX | 21.84 | N/A | N/A |
Touchstone Sands Capital Select Growth Y | |||
TIBRX | 31.71 | N/A | N/A |
Thornburg Investment Income Builder R3 | |||
BIRDX | 8.53 | N/A | N/A |
iShares Developed Real Estate Idx Instl |